STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1
Clinical trial NCT07038915 · WITHDRAWN
Trial details
- NCT number
- NCT07038915
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-28
- Primary completion
- 2025-07-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.